Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "advisory"

164 News Found

CII elects R Mukundan as President for 2026-27, Suchitra K Ella named President-Designate
People | May 13, 2026

CII elects R Mukundan as President for 2026-27, Suchitra K Ella named President-Designate

Shashwat Goenka takes over as Vice President of industry body


Industrial AI takes center stage at ARC Industry Leadership India Forum 2026
Supply Chain | May 08, 2026

Industrial AI takes center stage at ARC Industry Leadership India Forum 2026

The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore


Experts call for easing access to 2mg and 4mg nicotine replacement therapies
Public Health | May 07, 2026

Experts call for easing access to 2mg and 4mg nicotine replacement therapies

With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical


Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025
Biopharma | May 05, 2026

Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025

The private funding rose 38% amid growing international collaborations and CDMO demand


Indegene named leader in ISG provider lens 2026 for life sciences digital commercial operations
Digitisation | May 05, 2026

Indegene named leader in ISG provider lens 2026 for life sciences digital commercial operations

The ISG assessment highlights Indegene’s deep domain expertise, proprietary technology stack, and expanding use of AI and GenAI to drive more integrated, data-led commercial execution across the life sciences value chain


Pawan Varshney elevated to Director of Finance – South Asia at Cepheid
People | May 01, 2026

Pawan Varshney elevated to Director of Finance – South Asia at Cepheid

His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia


Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics
interviews | April 29, 2026

Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics

Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies


Lilly buys Ajax Therapeutics for up to $2.3 billion to target rare blood cancers
Biopharma | April 28, 2026

Lilly buys Ajax Therapeutics for up to $2.3 billion to target rare blood cancers

Ajax's lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept clinical data to be presented later in 2026


Umang Vohra appointed Executive Chairman and Group CEO of Cohance Lifesciences
People | April 27, 2026

Umang Vohra appointed Executive Chairman and Group CEO of Cohance Lifesciences

Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role